Molecular Medicine

Healio spoke to Ashley Haggerty, MD, a board certified, fellowship-trained gynecologic oncologist at Hackensack Meridian Medical Group about recent advancements in endometrial cancer care.

Márta Korbonits, MD, PhD, DSc, FRCP, uncovered a passion for endocrinology from a series of inspirational lectures during her medical training.

From a curious child playing with a microscope to molecular physiology professor, Holly A. Ingraham, PhD, leads a career in molecular processes with a recent focus on how endocrine signals shape female physiology.

Mitchell A. Lazar, MD, PhD, has always been interested in organic chemistry, biochemistry and mental illness, which led him to delve into research on the regulation of gene expression in response to hormones, metabolites and drugs.

Healio and Cardiology Today present meeting highlights from the FH Foundation’s FH Global Summit on familial hypercholesterolemia, featuring the latest news in the use of cholesterol medication, patient screening, artificial intelligence and more.

ATLANTA — In this video exclusive, Daniel J. Rader, MD, chair of the department of genetics, chief of the division of translational medicine and human genetics, the Seymour-Gray Professor of Molecular Medicine at the University of Pennsylvania Perelman School of Medicine and chief science adviser for the FH Foundation, spoke with Katherine Wilemon, founder and CEO of the FH Foundation, about major takeaways from the FH Foundation’s FH Global Summit, which focused on familial hypercholesterolemia as a driver for precision public health.

The word “vagus” comes from the Latin “to wander.” Accordingly, the vagus nerve takes a meandering path through the body, impacting everything from digestion to immunity. As understanding of this pathway grew, clinicians and researchers saw it as a potential therapeutic target. The mental health community capitalized first, using vagus nerve stimulation as a staple of epilepsy and depression treatment for decades.